P

Inventor

GOLDMAN MILDRED M

US19 patents
⚠️ This page may combine multiple inventors who share the name “GOLDMAN MILDRED M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

QUEST DIAGNOSTICS INVEST INC

14 patents
US9057732B2Jun 16, 2015

Mass spectrometry assay for congenital adrenal hyperplasia

QUEST DIAGNOSTICS INVEST INC9 citations92
US10697980B2Jun 30, 2020

Mass spectrometry assay for congenital adrenal hyperplasia

QUEST DIAGNOSTICS INVEST INC2 citations84
US10429396B2Oct 1, 2019

Mass spectrometry assay for congenital adrenal hyperplasia

QUEST DIAGNOSTICS INVEST INC4 citations84
US9921231B2Mar 20, 2018

Mass spectrometry assay for congenital adrenal hyperplasia

QUEST DIAGNOSTICS INVEST INC6 citations84
US9678087B2Jun 13, 2017

Methods for detecting estrone by mass spectrometry

QUEST DIAGNOSTICS INVEST INC4 citations84
US9541562B2Jan 10, 2017

Mass spectrometry assay for congenital adrenal hyperplasia

QUEST DIAGNOSTICS INVEST INC7 citations84
US8674291B2Mar 18, 2014

Mass spectrometry assay for congenital adrenal hyperplasia

QUEST DIAGNOSTICS INVEST INC7 citations84
US8017015B2Sep 13, 2011

Monolithic column chromatography

QUEST DIAGNOSTICS INVEST INC13 citations84
US11280798B2Mar 22, 2022

Methods for detecting estrone by mass spectrometry

QUEST DIAGNOSTICS INVEST INC1 citations73
US10948501B2Mar 16, 2021

Mass spectrometry assay for congenital adrenal hyperplasia

QUEST DIAGNOSTICS INVEST INC1 citations73
US10422804B2Sep 24, 2019

Methods for detecting estrone by mass spectrometry

QUEST DIAGNOSTICS INVEST INC2 citations73
US12584928B2Mar 24, 2026

Methods for detecting estradiol by mass spectrometry

QUEST DIAGNOSTICS INVEST INC0 citations62
US12196765B2Jan 14, 2025

Mass spectrometry assay for congenital adrenal hyperplasia

QUEST DIAGNOSTICS INVEST INC0 citations62
US10317377B2Jun 11, 2019

Monolithic column chromatography

QUEST DIAGNOSTICS INVEST INC1 citations62

GHOSHAL AMIT

2 patents

QUEST DIAGNOSTICS INVEST LLC

2 patents

GOLDMAN MILDRED M

1 patent